Motesanib - CISMeF

Preferred Label : Motesanib;

NCIt definition : An orally bioavailable receptor tyrosine kinase inhibitor with potential antineoplastic activity. AMG 706 selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), Kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.;

UNII : U1JK633AYI;

InChIKey : RAHBGWKEPAQNFF-UHFFFAOYSA-N;

CAS number : 453562-69-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 453562-69-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Chemical formula : C22H23N5O;

ChEBI ID : CHEBI:51098;

Codes from synonyms : 341;

Details

Origin ID

C71896;

UMLS CUI

C2347295;

Automatic exact mappings (from CISMeF team)
- imetelstat [MeSH Supplementary Concept]
- motesanib [MeSH concept]
Currated CISMeF NLP mapping
- imetelstat [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- motesanib [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_salt_form
- Motesanib Diphosphate [NCIt concept]
is_free_acid_or_base_form_of
- Motesanib Diphosphate [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients